Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Alzheimer'S Research & Therapy
|
September 15, 2022
A longitudinal study on quality of life along the spectrum of Alzheimer's disease
Arenda Mank, Judith J M Rijnhart, Ingrid S van Maurik, et al.
Alzheimer'S Research & Therapy
|
August 5, 2023
Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals
Heleen M A Hendriksen, Aniek M van Gils, Argonde C van Harten, et al.
Alzheimer'S Research & Therapy
|
January 3, 2024
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
Lisa Waterink, Larissa A Masselink, Sven J van der Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 16, 2023
Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project
Mark A Dubbelman, Sietske A M Sikkes, Jarith L Ebenau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
August 2, 2023
Plasma-derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community-based study
Janina Krell-Roesch, Isabella Zaniletti, Jeremy A Syrjanen, et al.
JAMA Network Open
|
December 3, 2025
Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline
Calvin Trieu, Argonde C van Harten, Mardou S S A van Leeuwenstijn, et al.
Neurology
|
July 10, 2024
Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia
Pieter J van der Veere, Jeroen Hoogland, Leonie N C Visser, et al.
Alzheimer'S Research & Therapy
|
February 6, 2026
Real-world diagnostic performance of blood-based biomarkers for Alzheimer's disease: robust performance except after stroke and high charlson comorbidity index
Sinthujah Vigneswaran, Inge M W Verberk, Rebecca Z Rousset, et al.
JAMA Network Open
|
July 10, 2025
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum
Diederick M de Leeuw, Calvin Trieu, Ellen M Vromen, et al.
Alzheimer'S Research & Therapy
|
September 3, 2022
Longitudinal change in ATN biomarkers in cognitively normal individuals
Jarith L Ebenau, Denise Visser, Lior A Kroeze, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Alzheimer'S Research & Therapy
|
September 15, 2022
A longitudinal study on quality of life along the spectrum of Alzheimer's disease
Arenda Mank, Judith J M Rijnhart, Ingrid S van Maurik, et al.
Alzheimer'S Research & Therapy
|
August 5, 2023
Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals
Heleen M A Hendriksen, Aniek M van Gils, Argonde C van Harten, et al.
Alzheimer'S Research & Therapy
|
January 3, 2024
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
Lisa Waterink, Larissa A Masselink, Sven J van der Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 16, 2023
Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project
Mark A Dubbelman, Sietske A M Sikkes, Jarith L Ebenau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
August 2, 2023
Plasma-derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community-based study
Janina Krell-Roesch, Isabella Zaniletti, Jeremy A Syrjanen, et al.
JAMA Network Open
|
December 3, 2025
Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline
Calvin Trieu, Argonde C van Harten, Mardou S S A van Leeuwenstijn, et al.
Neurology
|
July 10, 2024
Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia
Pieter J van der Veere, Jeroen Hoogland, Leonie N C Visser, et al.
Alzheimer'S Research & Therapy
|
February 6, 2026
Real-world diagnostic performance of blood-based biomarkers for Alzheimer's disease: robust performance except after stroke and high charlson comorbidity index
Sinthujah Vigneswaran, Inge M W Verberk, Rebecca Z Rousset, et al.
JAMA Network Open
|
July 10, 2025
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum
Diederick M de Leeuw, Calvin Trieu, Ellen M Vromen, et al.
Alzheimer'S Research & Therapy
|
September 3, 2022
Longitudinal change in ATN biomarkers in cognitively normal individuals
Jarith L Ebenau, Denise Visser, Lior A Kroeze, et al.
Page
of 8